As of 2025-04-22, the Relative Valuation of Selecta Biosciences Inc (SELB) is (1.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -237.6%.
The range of the Relative Valuation is (2.11) - 0.82 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 23.0x | 14.0x |
| Forward P/E multiples | 23.5x - 32.2x | 30.5x |
| Fair Price | (2.11) - 0.82 | (1.21) |
| Upside | -339.5% - -7.3% | -237.6% |
| Date | P/E |